Session Details

U066 Pediatric Dermatological Surgery Pearls

Sat, Mar 28, 7:30 AM - 8:30 AM
Bluebird 2D
1 CME Available Focus Session Upcoming
View Map

DESCRIPTION

This session will focus on surgical tips for the dermatologists interested in pursuing pediatric dermatological surgery and reminders for the expert. It will be filled with practical and simple pearls that will enhance the surgical experience specifically geared for younger patients that have different challenges compared to adult patients. This will include pearls for in-office procedures and surgical operating room procedures including perioperative preparation, laser surgery preparation, laser safety, suture techniques in pediatric skin, pediatric nail surgery, and post-operative complications management. This one-hour session will provide high yield pearls that will strengthen the surgical experience for patients and their families.

LEARNING OBJECTIVES

1.

Apply surgical suture techniques geared towards pediatric dermatologic surgery.

2.

Evaluate the pre-operative and post operative needs of pediatric patients and their families for surgery.

3.

Develop practical skills required prior to the use of lasers and laser safety in pediatric patients.

SCHEDULE

7:30 AM

Introduction of the agenda and speakers

Fatmah Alzahrani, MD, FAAD

7:32 AM

Tips for skin surgery in children

7:43 AM

Treatment of pigmented lesions with a focus on Nevus of Ota and Ito

Sunil Kalia, MD

7:54 AM

Treatment of scars

Jill S. Waibel, MD, FAAD

8:05 AM

Treatment in patients with Skin of Color

Saad Al-Ajlan, MD

8:16 AM

Treatment of vascular lesions

Roy G. Geronemus, MD, FAAD

8:27 AM

Questions

DIRECTOR

Fatmah Alzahrani, MD, FAAD

Fatmah Alzahrani, MD, FAAD

SPEAKERS

Saad Al-Ajlan, MD

Saad Al-Ajlan, MD

Roy G. Geronemus, MD, FAAD

Roy G. Geronemus, MD, FAAD

Sunil Kalia, MD

Sunil Kalia, MD

Jill S. Waibel, MD, FAAD

Jill S. Waibel, MD, FAAD

DISCLOSURES

Saad Al-Ajlan, MD

No financial relationships exist with ineligible companies.

Fatmah Alzahrani, MD, FAAD

No financial relationships exist with ineligible companies.

Roy G. Geronemus, MD, FAAD

Allergan, Inc – Investigator(Grants/Research Funding); Allergan, Inc. – Advisory Board(Grants/Research Funding); ArchiMedus – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); Lutronic – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); New York Stem Cell Foundation – Investigator(Grants/Research Funding); Syneron Candela – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding);

Sunil Kalia, MD

AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); Bausch Health – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Leo Pharma Inc – Other(Grants/Research Funding); Leo Pharma Inc. – Consultant(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); UBC Dermatology – Board of Directors(Other Financial Benefit);

Jill S. Waibel, MD, FAAD

Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); BellaMia Technologies Inc. – Advisory Board(No Compensation Received); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding), Speaker(No Compensation Received); Galderma – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Investigator(Grants/Research Funding); Lumenis – Advisory Board(Honoraria), Consultant (1099 relationship)(No Compensation Received), Speaker(Honoraria); Neuronetics NeuroStar – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);